A carregar...
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI AG
2022-04-01
|
Colecção: | International Journal of Molecular Sciences |
Assuntos: | |
Acesso em linha: | https://www.mdpi.com/1422-0067/23/9/5009 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|